Submission to the Smokefree Environments and Regulated Products (Vaping) Amendment Bill

LFNZ is strongly in favour of resourcing programmes that increase complete smoking cessation, rather than encouraging people who smoke to switch their nicotine addiction. The scientific evidence regarding the effectiveness of vaping (Electronic Nicotine Delivery Systems or ENDS) as a smoking cessation aid is still being debated, this is partly due to the diversity of […]

Questions for Pharmac as lung cancer patients continue to die prematurely

We have written to the Health Select Committee, further to our petition, urging that lung cancer be declared a national health priority and for the three remaining treatments we recommended last March be funded in 1st line for lung Cancer. Key facts – – Lung cancer patients suffer premature death in New Zealand, because they […]

Submission for the Inquiry into health inequities for Maori

Lung Foundation New Zealand, filed a submission for the inquiry into health inequities for Maori, which has been led by the Maori Affairs Committee. LFNZ presented to the committee on Monday 4th November and answered questions pertaining to its submission. We hope this inquiry will help NZ take the bold steps ahead that will eliminate […]

Response to the Cancer Action Plan 2019 – 2029

We are really pleased after two years to now have a draft cancer plan to review and acknowledge the work that has gone into this draft plan. First up, we should record how disappointing it was, for our cause, and CANGO (Cancer Non-Governmental Organisations) of which Lung Foundation NZ is a member, to not be […]

Our submission to the Health Select Committee

We recently presented to the Health Select Committee. Sincere thanks to the many brave patients and carers for their letters, which highlight the terrible inequity that exists for lung cancer in NZ. Click to view our submission – 2019 July – Lung Foundation NZ – Health Select Committee – Hearing for Lung Cancer Petition Petition […]

See How NZ’s Publicly-Funded Lung Cancer Treatment Options Compare

This report provides a direct comparison of Non-Small Cell Lung Cancer Treatment Options: New Zealand and Australia versus European Society for Medical Oncology (ESMO) Guidelines. Sadly this report demonstrates how far behind Pharmac is with reimbursing standard of care treatments for NZ’s Biggest Cancer Killer and why lung cancer patients die prematurely in New Zealand. […]